It has been described that c-Src also enhances resistance to apoptosis by accelerating the ubiquination and proteasomal degradation of the protein Bcl-2 interacting killer (Bik) via the MAP kinase signaling pathway in CRC and lung cancer cells [16, 25, 40]. Here, BIK is linked to lung carcinoma.